Epithelial-mesenchymal transition: An emerging target in tissue fibrosis
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Epithelial-mesenchymal transition (EMT) is involved in a variety of tissue fibroses. Fibroblasts/myofibroblasts derived from epithelial cells contribute to the excessive accumulation of fibrous connective tissue in damaged tissue, which can lead to permanent scarring or organ malfunction. Therefore, EMT-related fibrosis cannot be neglected. This review highlights the findings that demonstrate the EMT to be a direct contributor to the fibroblast/myofibroblast population in the development of tissue fibrosis and helps to elucidate EMT-related anti-fibrotic strategies, which may enable the development of therapeutic interventions to suppress EMT and potentially reverse organ fibrosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The basics of epithelial-mesenchymal transition
Kalluri, R., & Weinberg, R. A. (2009) · Journal of Clinical Investigation · doi:10.1172/jci39104 · Cited by 10,196 · cited 2×
“This change is accompanied by a reduction in the expression of epithelial markers, the acquisition of a spindle-cell shape, and the expression of mesenchymal markers, such as fibroblast-specific protein-1 (FSP1), vimentin, N-cadherin, and a-smooth muscle actin (a-SMA).(4,7,8) The type 2 EMTendows cells with the capaci…”
BackgroundArnold, L., Henry, A., Poron, F., Baba-Amer, Y., van Rooijen, N., Plonquet, A., Gherardi, R. K., & Chazaud, B. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20070075 · Cited by 2,002
Formation and function of the myofibroblast during tissue repair
Hinz, B. (2007) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700613 · Cited by 1,658 · cited 1×
“Stress is important to sustain the MF phenotype, and a condition with stress release often drives MFs toward suicide.(130) It has been demonstrated that both the pharmacological disruption of this mechanotransduction pathway, such as the ROCK inhibitor fasudil, and the remodeling of the ECM composition can induce fibr…”
BackgroundOrtiz, L. A., DuTreil, M., Fattman, C., Pandey, A. C., Torres, G., Go, K., & Phinney, D. G. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0704421104 · Cited by 1,019
Aberrant Wnt/β-Catenin Pathway Activation in Idiopathic Pulmonary Fibrosis
Chilosi, M., Poletti, V., Zamò, A., Lestani, M., Montagna, L., Piccoli, P., Pedron, S., Bertaso, M., Scarpa, A., Murer, B., et al. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64282-4 · Cited by 708
Mi, S., Li, Z., Yang, H.-Z., Liu, H., Wang, J.-P., Ma, Y.-G., Wang, X.-X., Liu, H.-Z., Sun, W., & Hu, Z.-W. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1004081 · Cited by 370 · cited 1×
“Recently, Mi et al.(122) found that blocking IL-17A, a glycoprotein secreted from IL-17-producing cells, can inhibit reverse pulmonary fibrosis through both TGF-b1-dependent and -independent mechanisms.”
BackgroundKulkarni, A. A., Thatcher, T. H., Olsen, K. C., Maggirwar, S. B., Phipps, R. P., & Sime, P. J. (2011) · PLoS ONE · doi:10.1371/journal.pone.0015909 · Cited by 189 · cited 2×
“A focal adhesion kinase inhibitor was also capable of reversing the myofibroblast phenotype.140 In addition, two previous studies have reported that capsaicin, the pungentphenolic constituent of various peppers, can induce the dedifferentiation of myofibroblasts to hepatic stellate cells by anti-fibrotic and anti-infl…”
BackgroundVedrenne, N., Coulomb, B., Danigo, A., Bonté, F., & Desmoulière, A. (2012) · Pathologie Biologie · doi:10.1016/j.patbio.2011.10.002 · Cited by 89 · cited 1×
“It has been demonstrated that both the pharmacological disruption of this mechanotransduction pathway, such as the ROCK inhibitor fasudil, and the remodeling of the ECM composition can induce fibroblast/myofibroblast apoptosis.(131,132) Cell transplantation has been documented as another effective method for promoting…”
Background
Cited by
Marconi, G. D., Fonticoli, L., Rajan, T. S., Pierdomenico, S. D., Trubiani, O., Pizzicannella, J., & Diomede, F. (2021) · Cells · doi:10.3390/cells10071587 · Cited by 410
Role of JAK/STAT in Interstitial Lung Diseases; Molecular and Cellular Mechanisms
Montero, P., Milara, J., Roger, I., & Cortijo, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22126211 · Cited by 254
Hatipoglu, O. F., Uctepe, E., Opoku, G., Wake, H., Ikemura, K., Ohtsuki, T., Inagaki, J., Gunduz, M., Gunduz, E., Watanabe, S., et al. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111633 · Cited by 67
The Hedgehog Signaling Pathway in Idiopathic Pulmonary Fibrosis: Resurrection Time
Effendi, W. I., & Nagano, T. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms23010171 · Cited by 59
Al Saihati, H. A., Badr, O. A., Dessouky, A. A., Mostafa, O., Samir Farid, A., Aborayah, N. H., Abdullah Aljasir, M., Baioumy, B., Mahmoud Taha, N., El-Sherbiny, M., et al. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.112934 · Cited by 17
Metadata
- Authors
- Li, M., Luan, F., Zhao, Y., Hao, H., Zhou, Y., Han, W., & Fu, X.
- Venue
- Experimental Biology and Medicine
- Publisher
- Frontiers Media SA
- Published
- 2015-09-11
- Volume
- 241
- Issue
- 1
- Pages
- 1-13
- ISSN
- 0071-3384 (ISSN-L)
- 1535-3702
- 1535-3699
- OpenAlex
- W2193392580
- Cited by
- 151
- References
- 8
- FWCI
- 3.73
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Epithelial-mesenchymal transition: An emerging target in tissue fibrosis. https://app.cochat.ai/papers/10.1177/1535370215597194
- The paper
- Li, M., Luan, F., Zhao, Y., Hao, H., Zhou, Y., Han, W., & Fu, X. (2016). Epithelial-mesenchymal transition: An emerging target in tissue fibrosis. Experimental Biology and Medicine. https://doi.org/10.1177/1535370215597194
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.